Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Universidad Católica de Valencia San Vicente Mártir
Valencia, EspañaPublications in collaboration with researchers from Universidad Católica de Valencia San Vicente Mártir (2)
2024
2021
-
Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial
European Journal of Cancer, Vol. 148, pp. 382-394